FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136393217> ?p ?o ?g. }

• W3136393217 endingPage "1" @default.
• W3136393217 startingPage "1" @default.
• W3136393217 abstract "Hyperinflammation and cytokine storm has been noted as a poor prognostic factor in patients with severe pneumonia related to coronavirus disease 2019 (COVID-19). In COVID-19, pathogenic myeloid cell overactivation is found to be a vital mediator of damage to tissues, hypercoagulability, and the cytokine storm. These cytokines unselectively infiltrate various tissues, such as the lungs and heart, and nervous system. This cytokine storm can hence cause multi-organ dysfunction and life-threatening complications. Mavrilimumab is a monoclonal antibody (mAb) that may be helpful in some cases with COVID-19. During an inflammation, Granulocyte-macrophage colony-stimulating factor (GM-CSF) release is crucial to driving both innate and adaptive immune responses. The GM-CSF immune response is triggered when an antigen attaches to the host cell and induces the signaling pathway. Mavrilimumab antagonizes the action of GM-CSF and decreases the hyperinflammation associated with pneumonia in COVID-19, therefore strengthening the rationale that mavrilimumab when added to the standard protocol of treatment could improve the clinical outcomes in COVID-19 patients, specifically those patients with pneumonia. With this review paper, we aim to demonstrate the inhibitory effect of mavrilimumab on cytokine storms in patients with COVID-19 by reviewing published clinical trials and emphasize the importance of extensive future trials." @default.
• W3136393217 created "2021-03-29" @default.
• W3136393217 creator A5000162279 @default.
• W3136393217 creator A5002997348 @default.
• W3136393217 creator A5013551371 @default.
• W3136393217 creator A5015611293 @default.
• W3136393217 creator A5027730960 @default.
• W3136393217 creator A5034585339 @default.
• W3136393217 creator A5036672295 @default.
• W3136393217 creator A5042960436 @default.
• W3136393217 creator A5048550686 @default.
• W3136393217 creator A5052545422 @default.
• W3136393217 creator A5058574429 @default.
• W3136393217 creator A5058675387 @default.
• W3136393217 creator A5073246790 @default.
• W3136393217 creator A5076000726 @default.
• W3136393217 creator A5086342418 @default.
• W3136393217 creator A5087836460 @default.
• W3136393217 creator A5090804516 @default.
• W3136393217 date "2021-01-01" @default.
• W3136393217 modified "2023-09-30" @default.
• W3136393217 title "Effectiveness of Mavrilimumab in Viral Infections Including SARS-CoV-2 Infection - A Brief Review" @default.
• W3136393217 cites W1967658373 @default.
• W3136393217 cites W1969040660 @default.
• W3136393217 cites W1971054351 @default.
• W3136393217 cites W1981345114 @default.
• W3136393217 cites W1992276547 @default.
• W3136393217 cites W2022303626 @default.
• W3136393217 cites W2030459851 @default.
• W3136393217 cites W2044255565 @default.
• W3136393217 cites W2102683332 @default.
• W3136393217 cites W2162640475 @default.
• W3136393217 cites W2164757104 @default.
• W3136393217 cites W2322706669 @default.
• W3136393217 cites W2759367587 @default.
• W3136393217 cites W2792100814 @default.
• W3136393217 cites W2949930962 @default.
• W3136393217 cites W3001118548 @default.
• W3136393217 cites W3009912996 @default.
• W3136393217 cites W3011610993 @default.
• W3136393217 cites W3011976215 @default.
• W3136393217 cites W3023088605 @default.
• W3136393217 cites W3030871984 @default.
• W3136393217 cites W3032190760 @default.
• W3136393217 cites W3035293132 @default.
• W3136393217 cites W3036767741 @default.
• W3136393217 cites W3036942428 @default.
• W3136393217 cites W3038753733 @default.
• W3136393217 cites W3045453828 @default.
• W3136393217 cites W3083971467 @default.
• W3136393217 doi "https://doi.org/10.3947/ic.2020.0109" @default.
• W3136393217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8032909" @default.
• W3136393217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34409778" @default.
• W3136393217 hasPublicationYear "2021" @default.
• W3136393217 type Work @default.
• W3136393217 sameAs 3136393217 @default.
• W3136393217 citedByCount "2" @default.
• W3136393217 countsByYear W31363932172022 @default.
• W3136393217 countsByYear W31363932172023 @default.
• W3136393217 crossrefType "journal-article" @default.
• W3136393217 hasAuthorship W3136393217A5000162279 @default.
• W3136393217 hasAuthorship W3136393217A5002997348 @default.
• W3136393217 hasAuthorship W3136393217A5013551371 @default.
• W3136393217 hasAuthorship W3136393217A5015611293 @default.
• W3136393217 hasAuthorship W3136393217A5027730960 @default.
• W3136393217 hasAuthorship W3136393217A5034585339 @default.
• W3136393217 hasAuthorship W3136393217A5036672295 @default.
• W3136393217 hasAuthorship W3136393217A5042960436 @default.
• W3136393217 hasAuthorship W3136393217A5048550686 @default.
• W3136393217 hasAuthorship W3136393217A5052545422 @default.
• W3136393217 hasAuthorship W3136393217A5058574429 @default.
• W3136393217 hasAuthorship W3136393217A5058675387 @default.
• W3136393217 hasAuthorship W3136393217A5073246790 @default.
• W3136393217 hasAuthorship W3136393217A5076000726 @default.
• W3136393217 hasAuthorship W3136393217A5086342418 @default.
• W3136393217 hasAuthorship W3136393217A5087836460 @default.
• W3136393217 hasAuthorship W3136393217A5090804516 @default.
• W3136393217 hasBestOaLocation W31363932171 @default.
• W3136393217 hasConcept C116675565 @default.
• W3136393217 hasConcept C126322002 @default.
• W3136393217 hasConcept C159047783 @default.
• W3136393217 hasConcept C2779134260 @default.
• W3136393217 hasConcept C3006700255 @default.
• W3136393217 hasConcept C3007834351 @default.
• W3136393217 hasConcept C3008058167 @default.
• W3136393217 hasConcept C524204448 @default.
• W3136393217 hasConcept C71924100 @default.
• W3136393217 hasConceptScore W3136393217C116675565 @default.
• W3136393217 hasConceptScore W3136393217C126322002 @default.
• W3136393217 hasConceptScore W3136393217C159047783 @default.
• W3136393217 hasConceptScore W3136393217C2779134260 @default.
• W3136393217 hasConceptScore W3136393217C3006700255 @default.
• W3136393217 hasConceptScore W3136393217C3007834351 @default.
• W3136393217 hasConceptScore W3136393217C3008058167 @default.
• W3136393217 hasConceptScore W3136393217C524204448 @default.
• W3136393217 hasConceptScore W3136393217C71924100 @default.
• W3136393217 hasIssue "1" @default.
• W3136393217 hasLocation W31363932171 @default.

• next